MOUNT PROSPECT, IL, Feb. 09, 2018 -- To help combat the opioid epidemic and assist in the prevention of prescription drug misuse, North Carolina and Oregon are now participating in the National Association of Boards of Pharmacy’s® (NABP’s®) prescription monitoring program (PMP) and data sharing system, NABP PMP InterConnect®.
|
|||
These two states have joined the secure national network of PMPs that allows authorized prescribers and pharmacists to access information about their patients’ controlled substance prescriptions across state lines. There are now 45 states participating in the program.
A report from the President’s Commission on Combating Drug Addiction and the Opioid Crisis highlights prescription drug monitoring programs as an important tool to aid in the fight against opioid abuse. Such systems can be used for early detection and prevention of drug abuse and addiction, and a national network like PMP InterConnect allows for a secure exchange of prescription data between states. It can also help identify patients who cross state lines to purchase drugs for the purposes of misuse or diversion.
“We provide a national PMP data sharing solution that brings the states together for a safe and secure exchange. North Carolina and Oregon were integrated seamlessly into our system, a system that is the only one of its kind and has been in operation since 2011,” said NABP President Jeanne Waggener, RPh, DPh. “We want to keep the public safe and help pharmacists and prescribing physicians flag potential instances of drug misuse, especially as it relates to the opioid epidemic.”
PMP InterConnect currently processes over 15 million requests and 18.5 million responses per month. It is free of charge for participating states. For more information about PMP InterConnect, visit www.nabp.pharmacy/PMP.
NABP is the independent, international, and impartial Association that assists its state member boards and jurisdictions for the purpose of protecting the public health.
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/9cf61071-2399-46b0-94f7-7118315c54b4
Larissa Doucette National Association of Boards of Pharmacy 847/391-4405 [email protected]


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Washington Post Publisher Will Lewis Steps Down After Layoffs
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



